Pathological Correlation of Inflammatory Cytokines with Neurocognitive Impairment in Pediatric Epilepsy. A Clinical Cross-Sectional Study
Inflammatory Cytokines and Neurocognition in Pediatric Epilepsy
DOI:
https://doi.org/10.69750/dmls.02.04.0123Keywords:
Pediatric epilepsy, cognitive impairment, cytokines, IL-6, TNF-α, IL-1β, neuroinflammation, WISC-IVAbstract
Background: Pediatric epilepsy is a common neurological condition characterized not only by recurrent seizures but also by notable disruptions in cognitive development during key stages of brain maturation. Recent studies have increasingly implicated neuroinflammatory processes—particularly those involving pro-inflammatory cytokines—as major contributors to both seizure activity and cognitive deterioration. Despite this, limited clinical evidence exists regarding the relationship between systemic inflammation and cognitive outcomes in epileptic children.
Objective: This study aimed to investigate the association between serum levels of key inflammatory cytokines (IL-6, TNF-α, and IL-1β) and cognitive performance in children diagnosed with epilepsy.
Methods: Between January 2022 and March 2023, 100 pediatric epilepsy patients, ages 5 to 16, were selected from two tertiary healthcare institutions in Pakistan for a cross-sectional analysis. The Wechsler Intelligence Scale for Children, Fourth Edition (WISC-IV) was used to assess cognitive ability. TNF-α, IL-1β, and IL-6 serum concentrations were measured by the enzyme-linked immunosorbent assay (ELISA). Multivariate linear regression and Pearson's correlation were used in the statistical analysis to find correlations between cytokine levels and cognitive scores.
Results: Serum levels of IL-6 (6.2 ± 1.1 pg/mL), TNF-α (7.9 ± 1.5 pg/mL), and IL-1β (5.0 ± 1.3 pg/mL) were substantially greater in participants with impaired cognitive function (Full Scale IQ < 85) than in those with normal cognitive function (p < 0.001). IL-6 and Full-Scale IQ showed a considerable negative connection (r = –0.65, p < 0.001), with the Processing Speed Index being most affected. While IL-1β was particularly associated with working memory problems, multivariate regression revealed that IL-6 and TNF-α were independent predictors of worse cognitive scores.
Conclusion: Systemic inflammation, marked by elevated cytokine levels, is significantly associated with cognitive impairment in pediatric epilepsy, independent of seizure frequency or antiepileptic medication. These findings underscore the importance of inflammatory biomarkers in predicting neurocognitive outcomes and suggest potential benefits of integrating cytokine assessment into routine clinical evaluation to identify high-risk patients and explore anti-inflammatory treatment strategies.
Downloads
References
Bartolini L, Moran MP, Norato G, Thomas B, Dick AD, Wells E, et al. Differential activation of neuroinflammatory pathways in children with seizures: a cross-sectional study. Seizure. 2021;91:150–8. doi:10.1016/j.seizure.2021.05.022
Arend J, Kegler A, Caprara ALF, Almeida C, Gabbi P, Pascotini ET, et al. Depressive, inflammatory, and metabolic factors associated with cognitive impairment in patients with epilepsy. Epilepsy Behav. 2018;86:49–57. doi:10.1016/j.yebeh.2018.07.007
Zhao K, Chen P, Alexander-Bloch A, Wei Y, Dyrba M, Yang F, et al. A neuroimaging biomarker for individual brain-related abnormalities in neurodegeneration (IBRAIN): a cross-sectional study. eClinicalMedicine. 2023;65:102276. doi:10.1016/j.eclinm.2023.102276
Zervides KA, Jern A, Nystedt J, Gullstrand B, Nilsson PC, Sundgren PC, et al. Serum S100A8/A9 concentrations and neuropsychiatric involvement in systemic lupus erythematosus: a cross-sectional study. BMC Rheumatol. 2022;6(1):38. doi:10.1186/s41927-022-00268-w
McGuire JL, Gill AJ, Douglas SD, Kolson DL, CHARTER Group. Central and peripheral markers of neurodegeneration in HIV-associated neurocognitive disorders. J Neurovirol. 2015;21(4):439–48. doi:10.1007/s13365-015-0333-3
Fagan AM, Henson RL, Li Y, Boerwinkle AH, Xiong C, Bateman RJ, et al. CSF biomarkers in Down syndrome vs. autosomal dominant Alzheimer’s disease: a cross-sectional study. Lancet Neurol. 2021;20(8):615–26. doi:10.1016/S1474-4422(21)00139-3
Zheng Y, Cai X, Wang D, Chen X, Wang T, Xie Y, et al. Lipid metabolism and cognition in stable-phase schizophrenia: Olink proteomics cross-sectional study. BMC Psychiatry. 2024;24:593. doi:10.1186/s12888-024-06054-x
Colgecen E, Celikbilek A, Keskin DT. Cognitive impairment in psoriasis: MoCA-based cross-sectional study. Am J Clin Dermatol. 2016;17(4):413–9. doi:10.1007/s40257-016-0187-3
Parisi GF, Diaferio L, Brindisi G, Indolfi C, Umano GR, Klain A, et al. Long-term sequelae of pediatric COVID-19: Italian pediatrician survey. Children (Basel). 2021;8(9):769. doi:10.3390/children8090769
Liu X, Ma Y, Ouyang R, Zeng Z, Zhan Z, Lu H, et al. Inflammation and neurocognitive dysfunction in obstructive sleep apnea. J Neuroinflammation. 2020;17(1):229. doi:10.1186/s12974-020-01905-2
Soares JZ, Valeur J, Šaltytė Benth J, Knapskog AB, Selbæk G, Bogdanovic N, et al. Vitamin D, cytokines, and AD biomarkers: cross-sectional study. J Alzheimers Dis. 2022;89(3):825–34. doi:10.3233/JAD-220407
Checkouri T, Missamou F, Pion SDS, Bikita P, Hemilembolo MC, Boussinesq M, et al. Cognitive impairment and Loa loa microfilaremia in Congo: cross-sectional study. PLoS Negl Trop Dis. 2023;17(6):e0011430. doi:10.1371/journal.pntd.0011430
Chen Y, Le D, Xu J, Jin P, Zhang Y, Liao Z. Gut microbiota dysbiosis and inflammation in late-life depression. Neuropsychiatr Dis Treat. 2024;20:399–414. doi:10.2147/NDT.S449224
Ruthirakuhan M, Herrmann N, Andreazza AC, Verhoeff NPLG, Gallagher D, Black SE, et al. Agitation, oxidative stress, and cytokines in Alzheimer disease. J Geriatr Psychiatry Neurol. 2020;33(4):175–84. doi:10.1177/0891988719874118
Alfaki DA, Hussein M, Hassan M, Eloraish AG, Elbasheir MM. Immune mediators in severe vs. uncomplicated malaria: cross-sectional study. Explor Immunol. 2023;3(4):406–15. doi:10.37349/ei.2023.00109
Williams ME, Stein DJ, Joska JA, Naudé PJW. CSF immune markers and HIV-associated neurocognitive impairment: systematic review. J Neuroimmunol. 2021;358:577649. doi:10.1016/j.jneuroim.2021.577649
Algul FE, Kaplan Y. Systemic immune-inflammation index as an indicator of Alzheimer’s disease severity. J Geriatr Psychiatry Neurol. 2025;38(3):214–22. doi:10.1177/08919887241280880
Yang H, Liao Z, Zhou Y, Gao Z, Mao Y. Serum albumin-globulin ratio & cognitive function: NHANES 2011–2014. Front Public Health. 2024;12:1375379. doi:10.3389/fpubh.2024.1375379
Williams ME, Naudé PJW. HIV-1 neuroinflammation and encephalitis pathology: systematic review of post-mortem studies. Rev Med Virol. 2024;34(1):e2519. doi:10.1002/rmv.2519
McGuire JL, Gill AJ, Douglas SD, Kolson DL, CHARTER Group. Complement system, neuronal injury, and cognition in HIV-infected youth. J Neurovirol. 2016;22(6):823–30. doi:10.1007/s13365-016-0460-5
Tan S, Chen W, Kong G, Wei L, Xie Y. Peripheral inflammation & neurocognitive impairment: mechanisms & implications. Front Aging Neurosci. 2023;15:1305790. doi:10.3389/fnagi.2023.1305790
Liang N, Nho K, Newman JW, Arnold M, Huynh K, Meikle PJ, et al. Peripheral inflammation, brain atrophy & cognitive decline in MCI/AD. Sci Rep. 2024;14(1):17423. doi:10.1038/s41598-024-67177-5
Muscal E, Brey RL. Neurologic manifestations of systemic lupus erythematosus. Neurol Clin. 2010;28(1):61–73. doi:10.1016/j.ncl.2009.09.004
Qiao S, Li H, Guo F, Cai G, Zhang Y. Cognitive impairment & inflammatory markers in WMH: narrative review. Ann Transl Med. 2022;10(7):421. doi:10.21037/atm-22-1016
Thompson LJ, Genovese J, Hong Z, Singh MV, Singh VB. HIV-associated neurocognitive disorder: molecular pathology. Int J Mol Sci. 2024;25(9):4697. doi:10.3390/ijms25094697
Owens CD, Bonin Pinto C, Mukli P, Szarvas Z, Peterfi A, Detwiler S, et al. Vascular mechanisms of MCI progression post-COVID-19. PLoS One. 2023;18(8):e0289508. doi:10.1371/journal.pone.0289508
Li M, Li R, Lyu JH, Chen JH, Wang W, Gao ML, et al. Retinal choroidal thickness in Alzheimer’s disease: cross-sectional study. J Alzheimers Dis. 2021;80(1):407–19. doi:10.3233/JAD-201142
Downloads
PlumX Metrics
Published
Issue
Section
How to Cite
